A potentially pivotal international conflict of laws matter is set to go before New York's top court in January, when it's scheduled to hear arguments on whether derivative shareholder lawsuits against German pharmaceutical and biotechnology company Bayer AG, and British multinational banking firm Barclays, can be litigated here in the Empire State.